Urigen Pharmaceuticals, Inc. Overview of IC/Painful Bladder Syndrome for IC Awareness Week

SAN FRANCISCO--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc. (OTCBB:URGP), focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.

MORE ON THIS TOPIC